| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.32 | 0.08 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |